IBRX vs JNJ: Which Is the Better Dividend Stock?
As of Nov 22, 2026, JNJ (Johnson & Johnson) screens as the stronger dividend stock, winning 3 of 3 head-to-head metrics. JNJ offers the higher yield at 1.98%, JNJ has the higher dividend-safety score.
Key facts: IBRX vs JNJ
Data as of · Source: SmarterDividends data
- As of Nov 22, 2026, Johnson & Johnson (JNJ) has the higher forward dividend yield at 1.98%, versus 0.00% for ImmunityBio, Inc. (IBRX).
- By SmarterDividends' count as of Nov 22, 2026, IBRX has raised its dividend for 0 consecutive years and JNJ for 61.
Cite this page
SmarterDividends, "IBRX vs JNJ: Dividend Yield, Safety & Value Compared," updated Nov 22, 2026, https://smarterdividends.com/compare/ibrx-vs-jnj
| Metric | IBRX | JNJ |
|---|---|---|
| Forward yield | 0.00% | 1.98% |
| Annual dividend | $0.00 | $5.36 |
| Payout ratio | — | 80% |
| Years of growth | 0 yr | 61 yr |
| 5-yr dividend growth | — | 5.2% |
| 5-yr total return | — | 58% |
| Dividend safety score | — | 93 (A) |
| Fair value estimate | — | $126.35 |
| Upside to fair value | — | -53% |
| Frequency | — | quarterly |
| Market cap | $6.4B | $651.1B |
| P/E ratio | — | 41.0 |
Higher yield
JNJ
1.98%
Safer dividend
JNJ
Grade A
Faster growth
JNJ
5.2%
IBRX vs JNJ FAQ
Is IBRX or JNJ a better dividend stock?
On the data, JNJ wins more head-to-head categories (3 vs 0). JNJ offers the higher yield (1.98%), while JNJ has the stronger dividend-safety score. The right pick depends on whether you prioritise income, safety or value.
Which has a higher dividend yield, IBRX or JNJ?
JNJ has the higher forward dividend yield at 1.98%, versus 0.00% for IBRX.
Is IBRX or JNJ safer?
Compare each stock's payout ratio, growth streak and cut history on its detail page to judge safety.
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.
